Bradford D. Dahms Theseus Pharmaceuticals, Inc. (THRX) insider trading activity

THRX Quotes by TradingView

Bradford D. Dahms is President and CFO of Theseus Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of THRX, which is worth approximately $0. The most recent transaction as insider was on Feb 14, 2024, when has been sold 8,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Bradford D. Dahms Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
8,150 Reduced 100.0%
0 Common Stock
Nov 30 2022
BUY
Open market or private purchase
$10,003 $6.66 p/Share
1,502 Added 19.65%
6,142 Common Stock
Dec 21 2021
BUY
Open market or private purchase
$19,995 $10.15 p/Share
1,970 Added 50.0%
1,970 Common Stock

Also insider at

SELB
SELECTA BIOSCIENCES INC Healthcare
Chief Financial Officer
BDD

Bradford D. Dahms

President and CFO
Watertown, MA

Track Institutional and Insider Activities on THRX

Follow Theseus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRX shares.

Notify only if

Insider Trading

Get notified when an Theseus Pharmaceuticals, Inc. insider buys or sells THRX shares.

Notify only if

News

Receive news related to Theseus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on THRX